Founder, Orthopaedic Surgeon
B
Biobytes
biobytes.kr
Website unreachable since Oct 17, 2026
Biobytes utilizes artificial intelligence to predict sarcopenia, a condition characterized by the loss of muscle mass and strength in aging populations. By providing early detection and risk assessment, the solution enables healthcare providers to implement timely interventions and improve patient outcomes.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 22 months ago
Funding
Raised to date
$440KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Biobytes utilizes artificial intelligence to predict sarcopenia, a condition characterized by the loss of muscle mass and strength in aging populations. By providing early detection and risk assessment, the solution enables healthcare providers to implement timely interventions and improve patient outcomes.